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Abstract 
Background: Co-morbid anxiety and depression 
are associated with hepatitis C. Co-
morbid depression is associated with increased 
medical symptom burden, poor quality of life and 
poor adherence to self-care regimens. However, in 
Pakistan, the data assessing the psychiatric aspect of 
Hepatitis C is limited. 
Objective: The objective of this study was to 
evaluate the frequency of anxiety and depression in 
patients with Hepatitis C at a public sector liver 
centre in Pakistan. 
Methods: Participants who were positive for 
hepatitis C were selected by non-probability 
convenience sampling. Informed consent was taken 
verbally and a questionnaire-based interview was 
implied. The questionnaire scored anxiety and 
depression on a verified Urdu translated version of 
Hospital Anxiety and Depression Scale (HADS). 
Data was analysed with SPSS v. 22. 
Results: Out of 146 participants 40% were males 
and 60% were females with an average age of 47.2 
years. Anxiety and depression were present in 47.9% 
and 41.8% patients of hepatitis C respectively. There 
was a significant association of drug use with 
anxiety (p=0.01) and depression (p=0.03). Urban 
residency was significantly associated with anxiety 
(p=0.04). On comparing means it was found that 
women had a higher average anxiety score compared 
to the males (10.2 ± 4.6 vs. 9.5 ± 4.6) while males had 
a higher average depression score compared with 
females (9.8 ± 4.3 vs. 9.3 ± 4.5). However, the 
correlation between gender and HADS scores was 
not significant. 
Conclusion: There is a high frequency of anxiety 
and depression among hepatitis C patients thus 
regular psychiatric screening, referral, treatment and 
follow-up is recommended. 
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Introduction 
It is estimated that 130 million people are affected by 
chronic hepatitis C infection worldwide1. The 
prevalence is as high as 16%, in some areas of 
Pakistan2. Increased medical symptoms, functional 
disability, medical costs, poor 
adherence, and increased risk of 
morbidity and mortality in patients with chronic 
medical disorders is associated with co-morbid 
depression3. According to WHO, it is the third main 
cause of disability-adjusted life year (DALY)4. 
Depression, being a major cause of disability; is 
predicted to be the second cause of disability in 
adults5. 
 An Irish study shows 24% frequency of 
anxiety disorder and 28% frequency of depressive 
disorders among Hepatitis C patients6. Chinese studies 
report the rate of psychiatric complaints in patients 
with chronic liver disease as 38.1%-51.1% while a 
similar study in Pakistan showed a much higher 
frequency of depression and anxiety i.e. 71.6% and 
70.6% respectively7-9. WHO estimates that in Pakistan 
the percentage of population having anxiety is 3.5% 
while that of depression is 4.2%10. The number of 
people with co-morbid HCV and depressive disorder 
(including minor depression) increased significantly 
between 1995 and 2005 from 18% to over 35% of all 
people with diagnosed HCV11. 
 The above-mentioned statistics indicate that 
high prevalence, chronicity, complications and 
cirrhosis are not the only problems of Hepatitis C. The 
disease has a psychiatric aspect as well. Lack of 
education and awareness about anxiety and 
depression leaves this aspect of illness unaddressed. 
Furthermore, lack of existing medical literature in this 
field, especially in developing countries makes it the 
need of the hour to channelize research work in this 
direction. This study will not only quantify the existing 
problem in our set-up but will also provide 
foundations for further studies that will throw light 
upon this issue. 
 
 
Received Date: 20/2/2019                        Revision Date: 23/3/2019                   Accepted for Publication: 21/9/2019 
Journal of Rawalpindi Medical College; 2019;23(S-2): 94-97 
 95 
Patients and Methods 
The descriptive cross-sectional study, with a 10 
months duration, was conducted at a public sector 
Liver Centre, at Holy Family Hospital, Rawalpindi. 
Patients who were anti HCV antibody and/or HCV 
RNA positive for more than 6 months were included; 
while those who had positive past and/or family 
history of depression and anxiety, any other co-
existing cause of cirrhosis (e.g. hepatitis B, primary 
biliary cirrhosis), other severe chronic diseases (e.g. 
COPD, cancer, heart failure or Ischemic heart disease), 
HIV positive or those on interferon treatment were 
excluded from the study. Non-probability convenience 
sampling technique was applied. Verbal consent was 
taken from subjects prior to being interviewed via 
questionnaire. The study was approved by ethical 
review board of Rawalpindi Medical University. 
 Social, demographic and psychological data 
was collected using a questionnaire based on a 
validated Urdu translated version of hospital anxiety 
and depression scale (HADS); proven by studies to be 
reliable12-14.  Socio-demographics included age, gender, 
marital status, drug use and address. Disease related 
data included means of diagnosis, treatment details 
and current status. Symptoms of anxiety and 
depression were scored using HADS and the scores 
were then classified as normal, borderline or cases.  
 The methods of descriptive and analytical 
statistics were applied. The data was analysed via 
SPSS version 22. The categorical variables were 
presented as percentages. Categorical data 
comparisons were performed using the χ2 and any p 
value < 0.05 was considered statistically significant. 
 
Results 
The study included 160 participants out of which 14 
did not satisfy the inclusion/exclusion criteria. Of the 
remaining 146 participants, 58 (40%) were males and 
88 (60%) were females with an average age of 47.2 
years. On assessing the frequency of anxiety, 47.9% 
were cases, 20.5% were borderline and 31.5% were 
normal; while assessing depression 41.8% were cases, 
25.3% were borderline and 32.9% were normal. The 
presence of anxiety and depression relative to the 
selected socio-demographic parameters is presented in 
Table I and Table II respectively.  There was a 
significant association of drug use with anxiety 
(p=0.01) and depression (p=0.03). Urban residency 
was significantly associated with anxiety (p=0.04), 
however, there was no significant association with 
depression. The correlation of HAD scale score with 
social and demographic parameters was studied by 
Pearson correlation and it did not show any other 
significant correlation. 
The frequency of cases of anxiety was higher in 
females compared with males (64.77% vs. 22.4%). The 
frequency is also higher in females for depression 
(46.59% vs. 34.48%). On comparing means it was 
found that women had a higher average anxiety score 
compared to the males (10.2 ± 4.6 vs. 9.5 ± 4.6). On the 
contrary, males had a higher average depression score 
compared to the females (9.8 ± 4.3 vs. 9.3 ± 4.5). 
However, the association gender with HADS scores 
was not significant. 
 
Social and 
demographic 
parameters 
Normal Border-
line 
Case P-
value 
Gender 
(%) 
Males 34 
(58.6%) 
11  
(19.0%) 
13 
(22.4%) 
0.49 
 
Females 12 
(13.6%) 
19  
(21.5%) 
57 
(64.8%) 
Age (%) Below 
50 
28 
(34.6%) 
17  
(21.0%) 
36 
(44.4%) 
0.84 
Equal to 
or 
above 
50 
18 
(27.7%) 
13  
(20.0%) 
34 
(52.3%) 
Marital 
status (%) 
Single 6 
(35.3%) 
3  
(17.6%) 
8 
(47.1%) 
0.14 
Married 40 
(31.0%) 
27  
(20.9%) 
62 
(48.1%) 
Drug use 
(%) 
User 6 
(35.3%) 
3  
(17.6%) 
8 
(47.1%) 
0.01 
Non-
user 
40 
(31.0%) 
27  
(20.9%) 
62 
(48.1%) 
Residency 
(%) 
 
Urban 30 
(30.0%) 
21  
(21.0%) 
49 
(49.0%) 
0.04 
Rural  16 
(34.8%) 
9  
(19.6%) 
21 
(45.6%) 
Table I: Anxiety relative to social and demographic 
parameters 
 
Discussion 
The critical finding of this study is the high 
frequency of anxiety (47.9%) and depression 
(41.8%). A previous study in Pakistan has 
reported a frequency of 70.6% and 71.6% of 
anxiety and depression respectively15. Likewise, 
another study in Pakistan described that 59.4% 
patients with hepatitis C had depression16. 
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Social and 
demographic 
parameters 
Normal Border 
line 
Case P-
value 
Gender 
(%) 
Males 25 
(43.1%) 
13  
(22.4%) 
20 
(34.5%) 
0.17 
Females 23 
(26.1%) 
24  
(27.3%) 
41 
(46.6%) 
Age (%) Below 
50 
34 
(42.0%) 
17  
(21.0%) 
30 
(37.0%) 
0.18 
Equal to 
or 
above 
50 
14 
(21.5%) 
20  
(30.8%) 
31 
(47.7%) 
Marital 
status (%) 
Single 8 
(66.7%) 
0  
(0.0%) 
4  
(33.3%) 
0.15 
 
Married 40 
(29.8%) 
37  
(27.6%) 
57 
(42.5%) 
Drug use 
(%) 
User 7 
(41.2%) 
3  
(17.6%) 
7  
(41.2%) 
0.03 
Non-
user 
41 
(31.8%) 
34  
(26.4%) 
54 
(41.9%) 
Residency 
(%) 
 
Urban 29 
(29.0%) 
26  
(26.0%) 
45 
(45.0%) 
0.11 
Rural 19 
(41.3%) 
11  
(23.9%) 
16 
(34.8%) 
Table II: Depression relative to social and 
demographic parameters 
 
In an Irish study, the frequency of anxiety and 
depression are 24% and 28% respectively6 whereas; in 
England, 18% screened positive for anxiety or 
depression17.  Australian studies have reported anxiety 
ranging between 41 to 44% and depression ranging 
from 27 to 34%18,19. A study from Serbia outlined 
depression up to 62.9 %20. There are higher frequencies 
of anxiety and depression among under-developed 
countries like Pakistan and Serbia, owing to lack of 
awareness, availability of psychiatric health care and 
lack of resources. 
In our study we found that there was a significant 
association of drug use with anxiety and depression 
this is in accord with previous studies that 
demonstrate association of alcohol and drug use with 
mood disorders and anxiety disorder21,22. Our study 
did not show any significant correlation of HADS 
scores with age; in concurrence with a past study23. On 
the contrary, other studies have shown increased rates 
of anxiety and depression with increasing age of the 
patient17-20. In our study there is higher frequency of 
cases among females compared with males which is in 
accord with previous studies4. However, in our study 
the mean score of anxiety is higher in females while 
that of depression being higher in males.  
 This study did not focus on the somatic 
complaints of chronic liver disease. However, other 
studies indicate that co-existing anxiety and 
depression are associated with increased somatic 
complaints, anger and stigma24-26. Studies also imply 
that anger and stigma are associated with hepatitis C27. 
 It is implicated that severity of depression correlates 
proportionately with quality of life13,25. Some studies 
show that hepatitis C is more likely to be associated 
with psychiatric disorders compared with hepatitis B 
and other chronic liver diseases28,29. 
The study employed HAD scale for detecting anxiety 
and depression. The use of this scale limits the 
diagnosis to a probable diagnosis instead of a definite 
diagnosis. Moreover, as the study employed non 
probability sampling and setting was a specialized 
liver centre the findings cannot be generalized to the 
hepatitis C population not in contact with medical 
care. 
 
Conclusion 
There is high frequency of anxiety and depression 
among Hepatitis C patients. It becomes imperative for 
health care professionals to be adequately equipped to 
diagnose the psychiatric aspects of Hepatitis C and to 
deal with it accordingly. Regular screening, 
subsequent referral for mental health treatment and 
follow-up in Hepatitis C patients is recommended. 
Moreover, public healthcare psychiatric institutes need 
to be expanded to allow specialists to refer patients.   
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